Lipigon Pharmaceuticals AB (OSTO:LPGO) LT-Debt-to-Total-Asset : 0.00 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Lipigon Pharmaceuticals AB LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Lipigon Pharmaceuticals AB's long-term debt to total assests ratio for the quarter that ended in Dec. 2023 was 0.00.

Lipigon Pharmaceuticals AB's long-term debt to total assets ratio stayed the same from Sep. 2022 (0.00) to Dec. 2023 (0.00).

Lipigon Pharmaceuticals AB LT-Debt-to-Total-Asset Historical Data

The historical data trend for Lipigon Pharmaceuticals AB's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lipigon Pharmaceuticals AB LT-Debt-to-Total-Asset Chart

Lipigon Pharmaceuticals AB Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

Lipigon Pharmaceuticals AB Quarterly Data
	Dec18	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial												-	-	-	-	-

Lipigon Pharmaceuticals AB LT-Debt-to-Total-Asset Calculation

Lipigon Pharmaceuticals AB's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	0	/	33.602
	=	0.00

Lipigon Pharmaceuticals AB's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (Q: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2023 )	/	Total Assets (Q: Dec. 2023 )
	=	0	/	33.602
	=

Lipigon Pharmaceuticals AB (OSTO:LPGO) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Lipigon Pharmaceuticals AB LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Lipigon Pharmaceuticals AB's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Lipigon Pharmaceuticals AB (OSTO:LPGO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lipigon Pharmaceuticals AB (OSTO:LPGO) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

9RP:Germany

Address

Tvistevagen 48 C, Umea, SWE, 90736

Website

https://www.lipigon.se

Lipigon Pharmaceuticals AB develops medicines for diseases caused by disorders of the body's handling of fats. It focuses on orphan drugs for unusual diseases where there is no adequate treatment.

Lipigon Pharmaceuticals AB (OSTO:LPGO) Headlines

No Headlines